U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713720) titled 'Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy' on Nov. 21.
Brief Summary: The goal of this clinical trial is to evaluate whether remote ischemic conditioning (RIC) is a safe and effective treatment for non-proliferative diabetic retinopathy (NPDR) in adults aged 40-80 years with type 2 diabetes. The study aims to address the limitations of current treatments for NPDR by using RIC, a technique involving repeated cycles of ischemia and hypoxia stimulation to activate protective mechanisms against retinal damage.
The main questions it aims to answer are:
Does RIC improve the Diabetic Retinopathy Severity Scor...